A new analysis in Clinical Gastroenterology and Hepatology (Brenner et al., Sept 2025) examines geodemographic trends in private equity (PE) acquisitions of U.S. gastroenterology practices from 2013–2023. The study confirms that GI has become a prime target for PE investment, driven by its high-volume procedures, strong ancillary revenue streams, and outpatient consolidation opportunities. What was once an abstract trend is now local and visible, directly shaping daily GI practice across the country. The findings underscore how PE is reshaping practice ownership and care delivery in gastroenterology.
Trending
- How Guardant aims to expand cancer screening with a blood test (Medtech Dive)
- Endoscope manufacturer faces $1M lawsuit after demo explosion (Becker’s GI & Endoscopy)
- AI-Based Red Density Score Predicts Clinical Outcomes in Ulcerative Colitis (GI & Endoscopy News)
- Machine Learning Improves Accuracy of Inflammatory Bowel Disease Identification Beyond ICD-10 Codes (Houston Methodist)
- No Surprises Act payment dispute process booms to $22.4 billion cost in 4 years: study (Medical Economics)
- PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Assisted Colonoscopy Worldwide (PR Newswire)
- Following Their Own Advice? Medscape Gastroenterologist Mental Health & Well-Being Report 2026 (Medscape)
- In-person therapist-delivered hypnotherapy versus smartphone-based self-guided hypnotherapy in IBS: a multicentre three-armed randomised controlled trial (GUT)
